microRNA information: hsa-miR-500b-5p

SectionIDlink
Mature name: hsa-miR-500b-5pmiRbase
Accession: MIMAT0016925miRbase
Precursor name: hsa-mir-500b miRbase
Precursor accession: MI0015903miRbase
Symbol: MIR500BHGNC
RefSeq ID: NR_036257GenBank
Sequence: AAUCCUUGCUACCUGGGU


Reported expression in cancers: hsa-miR-500b-5p

miRNAcancerregulationreportingPUBMEDmethod
hsa-miR-500b-5p

gastric cancerupregulation"Furthermore we found that miR-500 promoted gastric ......"25595906


Reported cancer pathway affected by hsa-miR-500b-5p

miRNAcancerpathwayreportingPUBMEDfunctional study


Reported cancer prognosis affected by hsa-miR-500b-5p

miRNAcancerprognosisreportingPUBMEDfunctional study
hsa-miR-500b-5p

gastric cancerpoor survival; malignant trasformation; progression"Here we report that the miR-500 directly repressed ......"25595906
hsa-miR-500b-5p

lung cancerprogression"We succeeded in establishing the MTA1 knockdown NS ......"22576802RNAi


Reported gene related to hsa-miR-500b-5p

miRNAcancergenereportingPUBMED


Expression profile in cancer corhorts:



Putative target regulations

miRNAGeneCancerInteractionCorrelation beta
hsa-miR-500b-5p
PLEKHM3
11 cancers: BLCA; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD
MirTarget
TCGA BLCA -0.119; TCGA ESCA -0.108; TCGA HNSC -0.239; TCGA LGG -0.252; TCGA LIHC -0.125; TCGA LUAD -0.092; TCGA LUSC -0.078; TCGA PAAD -0.147; TCGA PRAD -0.32; TCGA SARC -0.138; TCGA STAD -0.218
hsa-miR-500b-5p
STRN3
11 cancers: BLCA; BRCA; ESCA; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; SARC; STAD
MirTarget
TCGA BLCA -0.142; TCGA BRCA -0.169; TCGA ESCA -0.124; TCGA KIRP -0.069; TCGA LGG -0.075; TCGA LIHC -0.117; TCGA LUAD -0.07; TCGA PAAD -0.094; TCGA PRAD -0.124; TCGA SARC -0.108; TCGA STAD -0.121
hsa-miR-500b-5p
CCDC91
9 cancers: BLCA; BRCA; CESC; ESCA; LUAD; PAAD; PRAD; SARC; STAD
MirTarget
TCGA BLCA -0.09; TCGA BRCA -0.096; TCGA CESC -0.122; TCGA ESCA -0.174; TCGA LUAD -0.163; TCGA PAAD -0.149; TCGA PRAD -0.098; TCGA SARC -0.096; TCGA STAD -0.098
hsa-miR-500b-5p
SLITRK6
10 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LIHC; PAAD; PRAD; THCA; STAD
MirTarget
TCGA BLCA -0.476; TCGA BRCA -0.67; TCGA ESCA -0.586; TCGA HNSC -0.221; TCGA LGG -0.288; TCGA LIHC -0.365; TCGA PAAD -0.5; TCGA PRAD -0.246; TCGA THCA -0.327; TCGA STAD -0.685
hsa-miR-500b-5p
TGFB2
9 cancers: BLCA; CESC; HNSC; LUSC; PAAD; PRAD; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.231; TCGA CESC -0.327; TCGA HNSC -0.16; TCGA LUSC -0.213; TCGA PAAD -0.297; TCGA PRAD -0.098; TCGA THCA -0.27; TCGA STAD -0.19; TCGA UCEC -0.208
hsa-miR-500b-5p
FAM102B
9 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LUAD; PRAD; THCA
MirTarget
TCGA BLCA -0.09; TCGA BRCA -0.115; TCGA HNSC -0.148; TCGA KIRC -0.184; TCGA KIRP -0.081; TCGA LGG -0.081; TCGA LUAD -0.097; TCGA PRAD -0.099; TCGA THCA -0.148
hsa-miR-500b-5p
DPP8
11 cancers: BLCA; BRCA; CESC; HNSC; LGG; LIHC; LUAD; PAAD; PRAD; SARC; STAD
MirTarget
TCGA BLCA -0.142; TCGA BRCA -0.203; TCGA CESC -0.148; TCGA HNSC -0.301; TCGA LGG -0.264; TCGA LIHC -0.108; TCGA LUAD -0.135; TCGA PAAD -0.167; TCGA PRAD -0.381; TCGA SARC -0.107; TCGA STAD -0.075
hsa-miR-500b-5p
RAPGEF6
10 cancers: BLCA; BRCA; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; STAD
MirTarget
TCGA BLCA -0.161; TCGA BRCA -0.325; TCGA HNSC -0.513; TCGA KIRP -0.162; TCGA LGG -0.267; TCGA LUAD -0.172; TCGA LUSC -0.145; TCGA PRAD -0.464; TCGA SARC -0.191; TCGA STAD -0.05
hsa-miR-500b-5p
HMCN1
10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LGG; LUSC; PAAD; PRAD; STAD
MirTarget
TCGA BLCA -0.211; TCGA BRCA -0.322; TCGA ESCA -0.419; TCGA HNSC -0.387; TCGA KIRC -0.349; TCGA LGG -0.202; TCGA LUSC -0.417; TCGA PAAD -0.515; TCGA PRAD -0.176; TCGA STAD -0.479
hsa-miR-500b-5p
RPS6KB1
10 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD
MirTarget
TCGA BRCA -0.075; TCGA CESC -0.069; TCGA HNSC -0.064; TCGA KIRC -0.053; TCGA KIRP -0.128; TCGA LGG -0.125; TCGA LIHC -0.065; TCGA LUAD -0.088; TCGA PAAD -0.095; TCGA PRAD -0.123
hsa-miR-500b-5p
CHSY1
10 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA
MirTarget
TCGA BRCA -0.069; TCGA CESC -0.109; TCGA HNSC -0.122; TCGA KIRC -0.238; TCGA KIRP -0.105; TCGA LUAD -0.152; TCGA LUSC -0.065; TCGA PAAD -0.178; TCGA PRAD -0.096; TCGA THCA -0.074
hsa-miR-500b-5p
CYP1B1
9 cancers: ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD
MirTarget
TCGA ESCA -0.345; TCGA HNSC -0.342; TCGA LUAD -0.196; TCGA LUSC -0.269; TCGA PAAD -0.32; TCGA PRAD -0.22; TCGA SARC -0.259; TCGA THCA -0.668; TCGA STAD -0.668




Enriched cancer pathways of putative targets